Olanzapine leads to nonalcoholic fatty liver disease through the apolipoprotein A5 pathway
R. Li, W. Zhu, P. Huang…·X. Huang
This study shows olanzapine induces NAFLD via the apoA5 pathway by increasing hepatic apoA5 protein and sortilin levels, with APOA5 knockdown reversing steatosis.